DoD Autism, Idea Development Award | W81XWH 20 ARP IDA

Opportunity Information: Apply for W81XWH 20 ARP IDA

The Department of Defense Autism Research Program (ARP) Idea Development Award is a research funding opportunity meant to spark bold, early-stage work on autism spectrum disorder (ASD) that is innovative and potentially transformative. It is specifically positioned for high-risk, high-reward projects where the central value is the originality of the idea and the likelihood that the work could open up new directions in the field, generate influential preliminary data, or lead to major advances that improve real-world outcomes for people with ASD. In other words, it is less about incremental extensions of established lines of research and more about supporting ideas that could meaningfully shift understanding, clinical practice, or intervention strategies.

For the FY20 cycle, the program welcomed applications from any area of ASD research, while strongly encouraging proposals that respond to pressing needs identified by the autism community. The priority topics span both clinical and translational science as well as health services and implementation research. Examples include studies that test practical implementation strategies to increase the uptake of evidence-based practices in real settings, and projects that develop training programs or tools aimed at healthcare providers to improve care for individuals with ASD across the full lifespan and across different points in the healthcare system, including primary care, urgent and emergency care, and even disaster relief contexts. The opportunity also supports preclinical and mechanistic work, such as the assessment of novel therapeutics using valid preclinical models, investigations into why ASD presents so differently from person to person (heterogeneous clinical expression), and research on environmental risk factors that may contribute to ASD.

Another major emphasis is improving diagnosis and outcomes across the lifespan, including efforts that strengthen or modernize diagnostic approaches for children, adolescents, and adults. The program highlights the importance of life-course issues, encouraging research on what helps individuals with ASD succeed during major transitions toward independence, such as moving from school to work, increasing self-sufficiency, and navigating adult services. It also calls for work examining cultural and socioeconomic factors that affect how treatments work, how services are delivered, and who can access them, recognizing that disparities can shape outcomes as much as biology or clinical intervention design.

The opportunity further encourages studies focused on underexplored or complex dimensions of ASD, including mechanisms behind sex differences in diagnosis and presentation, as well as the biological and behavioral mechanisms underlying co-occurring conditions. These co-occurring conditions may include sleep disturbances, gastrointestinal problems, inflammation, aggression, depression, anxiety, attention deficit, and seizures, all of which can substantially affect daily functioning and quality of life. In addition, because this is a DoD-administered program, it explicitly notes military-relevant quality-of-life challenges, such as the impact of geographic relocation (for example, a military permanent change of station) on individuals with ASD and their families. Finally, the program invites studies that look back at long-term outcomes from previous clinical trials, either for ASD core symptoms or for interventions aimed at alleviating co-occurring conditions, which can help clarify durability of benefits, delayed effects, and real-world significance beyond short trial windows.

Administratively, this funding opportunity was issued by the Department of Defense, Department of the Army, through the U.S. Army Medical Research Acquisition Activity (USAMRAA). The opportunity number is W81XWH-20-ARP-IDA, and it falls under CFDA 12.420 (science and technology and other research and development). It allowed for funding through either grants or cooperative agreements, and eligibility was listed as unrestricted, meaning it was broadly open to many types of applicant organizations subject to any additional eligibility notes in the full announcement. The posting date was February 27, 2020, with an original closing date of July 16, 2020. The listing indicated an expectation of about five awards, while the award ceiling was shown as 0 in the source data, which typically signals that applicants needed to consult the full program announcement for the actual allowable budget limits or that the ceiling was not specified in the extracted summary.

• The Department of Defense, Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Autism, Idea Development Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on Feb 27, 2020.
• Applicants must submit their applications by Jul 16, 2020. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 5 candidate(s).
• Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.

Apply for W81XWH 20 ARP IDA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: